Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase I data demonstrate promising efficacy and safety for oral Raf kinase inhibitor

Dec. 3, 2002

Radiosensitizing effects of karenitecin in human glioma cells

Dec. 3, 2002

Evidence that trimidox sensitizes malignant glioma cells to ionizing radiation

Dec. 3, 2002

Inhibitors of tubulin polymerization prepared and tested at Aventis

Dec. 3, 2002

DN-101 evaluated in androgen-independent prostate cancer

Dec. 2, 2002

Data support use of TLK-286 in combination chemotherapy

Dec. 2, 2002

Simultaneous inhibition of angiogenesis and tumor growth with human MAb targeting integrins

Dec. 2, 2002

Aclacinomycin analogues produced by Finnish scientists using combinatorial biosynthesis

Dec. 2, 2002

SAR on a novel series of pyrrolobenzodiazepine antitumor agents

Dec. 2, 2002

U.K. team designs potent inhibitors of CDK1/CDK2 as potential anticancer agents

Dec. 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.